Driehaus Capital Management LLC Gamida Cell Ltd. Transaction History

Driehaus Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$3.85 - $6.44 $3.69 Million - $6.17 Million	-957,887 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$5.85 - $8.33 $91,774 - $130,681	-15,688 Reduced 1.61%	957,887 $6.14 Million
Q1 2021 May 17, 2021	SELL	$7.8 - $12.43 $11.4 Million - $18.1 Million	-1,458,220 Reduced 59.96%	973,575 $7.88 Million
Q4 2020 Feb 16, 2021	BUY	$4.07 - $11.0 $2.21 Million - $5.97 Million	542,704 Added 28.73%	2,431,795 $20.4 Million
Q3 2020 Nov 16, 2020	SELL	$3.93 - $4.59 $85,131 - $99,428	-21,662 Reduced 1.13%	1,889,091 $7.84 Million
Q2 2020 Aug 14, 2020	BUY	$2.79 - $6.5 $5.33 Million - $12.4 Million	1,910,753 New	1,910,753 $8.73 Million

Ticker GMDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,319,600
Market Cap $2.29M
Description
Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials ...

Get notified when there are updates to the investment portfolio of Driehaus Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Driehaus Capital Management LLC with notifications on news.